A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

Project: Research project

Project Details

StatusActive
Effective start/end date12/8/21 → 12/7/26

Funding

  • Genentech, Inc.: $11,542.00